Laurus Labs to Participate in 17th Annual Kotak Investor Conference on Feb 24
Laurus Labs will attend the 17th Annual Kotak Investor Conference in Mumbai on February 24, 2026. The company will hold in-person meetings with analysts and institutional investors. No Unpublished Price Sensitive Information will be disclosed during the interactions.
Participation in an investor conference is a standard practice for listed companies and typically does not have a significant immediate impact on the stock price unless material new information is disclosed.
The announcement is a routine disclosure about the company's participation in an investor conference and does not contain any new financial information or material business updates.
Laurus Labs Limited announced its participation in the 17th Annual Kotak Investor Conference. The company will engage in in-person meetings with analysts and investors. The conference is scheduled to take place in Mumbai on February 24, 2026.
This participation is in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has noted that the date of the meeting is subject to change based on exigencies from either the investors' or the company's side. Laurus Labs has also confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions.
What to do with a filing like this
Laurus Labs Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laurus Labs Limited. Read the original for the full detail.